News 10.26

Faced with the growing tension over labile blood products and the budget constraints of hospitals, decision-makers need evidence-based decision support tools. A budget and organizational impact model (OBIM, Organizational and Budget Impact Model) has been developed to assess the consequences of introducing a perioperative platelet-sparing autotransfusion device — the SAME™, designed by the French medtech company i-SEP — into operating rooms.

Read more
Event 09.26

Kick off of the SFAR Congress – French Society of Anesthesia and Intensive Care 2026! The congress opens its doors today at the Palais des Congrès in Paris and runs until Friday. Our team will be very happy to welcome you at booth No. 16 in partnership with Stago / Stago BioCare to share our news and recent publications with you.

Read more
Event 06.26

Opening of the JFEF 2026, Lille Grand Palais | June 17–19 The i-SEP team is here this week at the French Days of Exchange and Training, which bring together the French ecosystem of heart and thoracic surgery, anesthesia-intensive care, and perfusion. Same™ will be at the heart of the discussions and will especially be highlighted on Friday, June 19, with two presentations in two separate sessions.

Read more
Event 04.26

At NATA – The Network for PBM, Thrombosis and Haemostasis 2026, one message is coming through clearly: Patient Blood Management is not only about reducing transfusion. It is about preserving the patient’s own blood whenever possible. For i-SEP, this is exactly where intraoperative autotransfusion matters: supporting clinicians with a documented approach designed to recover both red blood cells and platelets through tangential filtration.

Read more
News 01.26

“Platelets are a rare and precious product… …this machine makes it possible to preserve platelets, which are essential for blood clotting.” A look back at our appearance on Le Mag de la Santé this Tuesday, December 16, on France TV. This segment perfectly illustrates the clinical and organizational value of our same™️ by i-SEP device in the operating room, as well as the key role played by hospital teams in adopting new practices. “Thanks to this technology, up to 630 ml of blood can be returned to the patient, as with a transfusion, with the essential difference that it is the patient’s own blood,” explains Dr. Rigal. Many thanks to Nantes University Hospital (CHU de Nantes), and in particular to Dr. Jean-Christophe Rigal, for his commitment, vision, and the quality of the work carried out on the ground with the entire cardiac surgery team, Prof. Jean-Christian Roussel and Prof. Bertrand Rozec. It is also the entire Nantes healthcare ecosystem that is being highlighted: a region that knows how to foster and support innovation thanks to close collaboration between hospitals, research laboratories, and support organizations, notably Atlanpole Biotherapies. The i-SEP adventure continues with renewed ambition, driven by a committed and determined team dedicated to support the evolution of autotransfusion practices in the operating room and to make this project a true success! #PatientBloodManagement #Autotransfusion Atlanpole – La French Care

Read more
Event 05.25

🩸When we talk about transfusion, we often think of emergency situations, growing needs, and blood shortages. But there’s another approach: giving patients back their own blood. That’s the vision we’re sharing this week at European Society of Anaesthesiology and Intensive Care congress, through one simple yet essential question: What if we could retransfuse a patient’s own red blood cells and platelets during surgery? This is no longer a theoretical concept. The same™ technology is already being used in several hospitals across France and Europe. And the interest keeps growing. Throughout the congress, we’ve had the pleasure of speaking with anesthesiologists, perfusionists, and healthcare professionals who came to learn more about this innovation, understand how it works, and most importantly, explore its real-world benefits: ➡️ Reduced use of banked blood products ➡️ Lower transfusion-related risks ➡️ Improved post-operative recovery ➡️ Significant cost savings for the healthcare system These on-the-ground conversations, shared experiences, and collective drive to improve clinical practice are what give real meaning to our work. A big thank you to everyone who stopped by to meet us. There’s still time to visit Amandine Combres and Guillaume Laurent at booth 2-08! 📆 Next meeting: Marseille, SFCTCV – Société Savante congress. See you there!

Read more
News 05.25

When you’re undergoing heart surgery, the last thing you want is to lose your blood-especially your platelets. It seems obvious, but turning intention into action was the real challenge. Today, that’s exactly what Lille University Hospital (CHU de Lille) has achieved by becoming the 15th center in France to adopt the innovative same™️technology by i-SEP in cardiac surgery. This installation is the direct result of the bold vision of the anesthesia team – Emmanuel Robin, Olivier Joulin, Moussa Mouhamed and the surgical team led by André Vincentelli. Their innovation project was even ranked #1 in September 2024! Denies Fanette – Benoit Dervaux. A brilliant recognition of their medical relevance and capacity for innovation. Expected outcomes: Reduced reliance on blood bank products (red blood cells & platelets), fewer potential complications, and enhanced safety for every patient. This intense week of deployment and training with the cardiopulmonary bypass team – Mounir Richa, Ahmed Hadhoum, Sébastien Cusquel, Gaetan Legrand, and others-clearly demonstrates how united and committed the entire cardiac surgery department at CHU de Lille truly is. Many thanks to them, and to the i-SEP team – Amandine Combres & Suzie Duval, for their training and support during the first procedures.

Read more
Event 04.25

💭 Looking back at hashtag#NATA25 at the Science Congress Center in Munich! To celebrate its 25th anniversary, NATA brought together experts and practitioners from around the world to discuss the major challenges in transfusion medicine. This year, the debates focused in part on Patient Blood Management (PBM), a true public health challenge. A must-attend event that drives innovation and advances clinical practices. And we are proud that i-SEP was part of it. A few highlights: 👉 Dr. Bertrand Rozec (CHU de Nantes) spoke during the session “Cell Salvage: The Past, Present and Game-Changing Future”, highlighting emerging technologies in the operating room, including our same™ solution. 👉 On friday morning, our joint symposium with HemoSonics shed light on blood management in cardiac surgery and obstetric: from coagulation monitoring with Quantra® and qLabs® FIB to comprehensive autotransfusion (platelets + red blood cells) thanks to same™. We had the pleasure of hearing inspiring talks from Aryeh Shander, Anne-Sophie Ducloy-Bouthors and Dr. med. Gösta Lotz, DESA, MA. 👉 Finally, our booth became a real hub for exchange, where we showcased our same™ technology. 💡 Why same™? Our solution addresses a major public health issue. By enabling hemorrhagic patients to recover both their red blood cells and their own platelets, i-SEP provides an impactful solution that offers significant patient benefits and cost savings for healthcare systems. In the context of strained blood management, this is an innovative solution that represents a major step forward in transfusion strategy. 📆 Next stop: Lisbon Join us at the European Society of Anaesthesiology and Intensive Care Congress, from May 25-27, 2025!

Read more
Event 04.25

📍 Live from #NATA25 in Munich! This morning, we had the pleasure of co-hosting a symposium with our partner HemoSonics, focusing on cardiac surgery and obstetrics, and exploring innovative approaches in coagulation monitoring and autotransfusion. 🕘 9:00 – 10:00 AM 📍 Audimax – Plenary Room Topic: “Patient Blood Management in cardiac surgery and obstetrics: from coagulation monitoring with Quantra® & qLabs® FIB to comprehensive autotransfusion (platelets + red blood cells) with same™” A big thank you to our speakers for their insightful presentations: ➡️ Aryeh Shander : “Introduction and Current State of PBM” ➡️ Anne-Sophie Ducloy-Bouthors : “Coagulation monitoring in obstetrics with Quantra® and qLabs® FIB” ➡️ Dr. med. Gösta Lotz, DESA, MA : “Initial feedback on same™ in Frankfurt: comprehensive autotransfusion (Platelets + RBC)” Our same™ technology is redefining transfusion strategies by enabling patients to recover their own red blood cells and platelets, significantly reducing the need for donor blood. 👋 Visit Guillaume Laurent and Georges Tabary at booth 1-02 to discover our solution and connect with us.

Read more
Event 04.25

📌 We were present at the J.E.P.U. Anesthesia & Intensive Care Congress with Stago BioCare! Each year, this congress brings together over 3,000 anesthesiologists and nurse anesthetists for two days of discussions on the latest advancements in the field, with around one hundred speakers and fifty exhibitors. A big thank you to everyone who stopped by to learn more about our same™ technology. 🩸 Our solution addresses a major public health issue. By enabling patients to recover their own red blood cells and platelets during hemorrhagic surgeries, i-SEP delivers significant benefits to patients while also generating cost savings for our healthcare system. In a context of increasing pressure on blood resources, this is an innovative solution that represents a major step forward in transfusion strategy. 📆 Save the date: Join us on April 24, 25, and 26 in Munich for the NATA congress.

Read more
123